Publication | Closed Access

The histone deacetylase inhibitor belinostat ameliorates experimental autoimmune encephalomyelitis in mice by inhibiting TLR2/MyD88 and HDAC3/ NF-κB p65-mediated neuroinflammation

InflammationAutoimmune DiseaseAllergyImmune Cell DevelopmentMedicineImmunologyImmune RegulationExperimental Autoimmune EncephalomyelitisAutoimmunityAutoimmune ResearchAutoantibodiesInnate ImmunityImmune FunctionImmunologic DiseaseImmunotherapyEpigenetic RegulationImmune DysregulationNeuroinflammation